These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 11067678)

  • 61. Medical devices; reclassification and codification of the nonabsorbable expanded polytetrafluoroethylene surgical suture. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Apr; 65(75):20734-5. PubMed ID: 11010640
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Medical devices; investigational device exemptions--FDA. Proposed rule.
    Fed Regist; 1998 Jul; 63(135):38131-8. PubMed ID: 10181246
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Medical devices; classification of temporomandibular joint implants--FDA. Final rule.
    Fed Regist; 1994 Dec; 59(243):65475-8. PubMed ID: 10172187
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Medical Devices; hematology and pathology devices; reclassification of automated blood cell separator device operating by filtration principle from class III to class II. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Feb; 68(40):9530-2. PubMed ID: 12617085
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Medical devices; Medical Device Data Systems. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Feb; 76(31):8637-49. PubMed ID: 21351676
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Financial disclosure by clinical investigators--FDA. Final rule.
    Fed Regist; 1998 Feb; 63(21):5233-54. PubMed ID: 10177332
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices), guidance for FDA reviewers and industry; availability--FDA. Notice.
    Fed Regist; 1998 Nov; 63(215):60009-10. PubMed ID: 10187389
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Immunology and Microbiology Devices; Classification of Anti-Saccharomyces cerevisiae (S. cerevisiae) Antibody (ASCA) Test Systems. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov; 65(226):70305-7. PubMed ID: 11503713
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cardiovascular devices; classification of electrocardiograph electrodes. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2011 Jul; 76(140):43582-5. PubMed ID: 21780327
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(224):64556-88. PubMed ID: 10339052
    [TBL] [Abstract][Full Text] [Related]  

  • 71. General hospital and personal use devices: proposed classification of liquid chemical sterilants and general purpose disinfectants--FDA. Proposed rule.
    Fed Regist; 1998 Nov; 63(215):59917-21. PubMed ID: 10187388
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effective date of requirement for premarket approval for automated external defibrillator systems. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Jan; 80(19):4783-91. PubMed ID: 25730922
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gastroenterology and urology devices; reclassification of the extracorporeal shock wave lithotripter. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug; 65(154):48609-12. PubMed ID: 11067714
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Medical devices; gastroenterology and urology devices; classification of the electrogastrography system. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Sep; 64(184):51442-4. PubMed ID: 11010709
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Medical devices; humanitarian use of devices--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(212):59217-22. PubMed ID: 10187383
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Natural rubber-containing medical devices; user labelling--FDA. Final rule; interpretation.
    Fed Regist; 1998 May; 63(87):24934-5. PubMed ID: 10179326
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Medical device warning letter pilot. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar; 64(44):11018-23. PubMed ID: 10557622
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cardiovascular and neurological devices; reclassification of two embolization devices. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Dec; 69(249):77898-900. PubMed ID: 15624254
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Medical devices; medical device reporting; baseline reports; stay of effective date--FDA. Final rule.
    Fed Regist; 1996 Jul; 61(148):39868-9. PubMed ID: 10159600
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.